Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

Novartis sets sights on connected inhaler

Plans 2019 launch for Qualcomm-partnered device

- PMLiVE

Dr Harley Simon moves from Merck & Co to ClinTec

Appointed chief medical office and EVP, client relations at the CRO

- PMLiVE

Merck & Co buys IOmet to boost immuno-oncology tech

Reports suggest it paid up to £280m for the Scottish biopharma company

Roche Basel Switzerland

AbbVie and Roche hoping for speedy venetoclax approval

Leukaemia treatment could reach US and EU markets within months

- PMLiVE

Celgene makes changes to its senior leadership team

Bob Hugin, Mark Alles, Jacqualyn Fouse and Scott Smith take on new roles

- PMLiVE

AbbVie takes ‘one-size-fits-all’ HCV regimen into phase III

Comes shortly after Gilead wins priority FDA review for its 'pan-genotypic' treatment

- PMLiVE

Learning from forecasting’s past

How previous eras will shape the pharma forecaster of the future

- PMLiVE

Baxalta agrees to $32bn Shire takeover

Deal will  create one of the industry's top rare disease firms

- PMLiVE

Nestle continues pharma drive with Seres collaboration

Food giant to investigate potential inflammatory bowel disease treatments

Key topics and trends for pharma and healthcare in 2016

Introducing PERSPECTIVE, the new digital magazine from Blue Latitude Health. A step beyond identifying top trends, this magazine explores key topics for 2016 for pharma and healthcare companies.

Blue Latitude Health

The art of managing digital communications from headquarters

Total control from headquarters or every market doing what they think is best?

Anthill Agency

- PMLiVE

Novo Nordisk files improved haemophilia B therapy in EU

Nonacog beta pegol is due to be submitted to US regulators in the next few months

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links